188 related articles for article (PubMed ID: 16647575)
1. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.
Kröger N; Zagrivnaja M; Schwartz S; Badbaran A; Zabelina T; Lioznov M; Ayuk F; Zander A; Fehse B
Exp Hematol; 2006 May; 34(5):688-94. PubMed ID: 16647575
[TBL] [Abstract][Full Text] [Related]
2. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
[TBL] [Abstract][Full Text] [Related]
3. Detection of minimal residual disease by polymerase chain reaction in B cell malignancies.
Moos M; Schulz R; Cremer F; Sucker C; Schmohl D; Döhner H; Goldschmidt H; Haas R; Hunstein W
Stem Cells; 1995 Dec; 13 Suppl 3():42-51. PubMed ID: 8747988
[TBL] [Abstract][Full Text] [Related]
4. Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats.
Frankel W; Chan A; Corringham RE; Shepherd S; Rearden A; Wang-Rodriguez J
Am J Hematol; 1996 Aug; 52(4):281-7. PubMed ID: 8701946
[TBL] [Abstract][Full Text] [Related]
5. Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantation.
Martinelli G; Terragna C; Zamagni E; Ronconi S; Tosi P; Lemoli R; Bandini G; Testoni N; Amabile M; Ottaviani E; Buonamici S; Soverini S; Montefusco V; de Vivo A; Bonifazi F; Tura S; Cavo M
Haematologica; 2000 Sep; 85(9):930-4. PubMed ID: 10980631
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of mixed hematopoietic chimerism in pediatric patients with leukemia after allogeneic stem cell transplantation by quantitative PCR analysis of variable number of tandem repeat and testis determination gene.
Wang LJ; Chou P; Gonzalez-Ryan L; Huang W; Haut PR; Kletzel M
Bone Marrow Transplant; 2002 Jan; 29(1):51-6. PubMed ID: 11840144
[TBL] [Abstract][Full Text] [Related]
7. Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantation.
Cotteret S; Belloc F; Boiron JM; Bilhou-Nabera C; Dumain P; Boyer C; Lacombe F; Reiffers J; Bernard P
Cytometry; 1998 Oct; 34(5):216-22. PubMed ID: 9822307
[TBL] [Abstract][Full Text] [Related]
8. Molecular monitoring of the tumor load predicts progressive disease in patients with multiple myeloma after high-dose therapy with autologous peripheral blood stem cell transplantation.
Lipinski E; Cremer FW; Ho AD; Goldschmidt H; Moos M
Bone Marrow Transplant; 2001 Nov; 28(10):957-62. PubMed ID: 11753551
[TBL] [Abstract][Full Text] [Related]
9. Development of microchimerism in pediatric patients after living-related liver transplantation.
Ueda M; Hundrieser J; Hisanaga M; Tanaka K; Wonigeit K; Pichlmayr R; Schlitt HJ; Yamaoka Y
Clin Transplant; 1997 Jun; 11(3):193-200. PubMed ID: 9193841
[TBL] [Abstract][Full Text] [Related]
10. Detection of relapse by sequential monitoring of chimerism in circulating CD34+ cells.
Thiede Ch; Lutterbeck K; Oelschlägel U; Kiehl M; Steudel Ch; Platzbecker U; Brendel C; Fauser AA; Neubauer A; Ehninger G; Bornhäuser M
Ann Hematol; 2002; 81 Suppl 2():S27-8. PubMed ID: 12611065
[TBL] [Abstract][Full Text] [Related]
11. Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards.
Gerard CJ; Olsson K; Ramanathan R; Reading C; Hanania EG
Cancer Res; 1998 Sep; 58(17):3957-64. PubMed ID: 9731509
[TBL] [Abstract][Full Text] [Related]
12. [DNA polymorphism, allogenic bone marrow transplantation and peripheral cell chimerism].
Brdicka R; Sieglová Z; Honzátková L; Dvoráková R; Hrabánek J; Kobylka P; Vítek A; Sedlácek P; Starý J
Cas Lek Cesk; 1998 Feb; 137(4):110-9. PubMed ID: 9531733
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection.
Dubovsky J; Daxberger H; Fritsch G; Printz D; Peters C; Matthes S; Gadner H; Lion T; Muller-Bérat N
Leukemia; 1999 Dec; 13(12):2059, 2060-9. PubMed ID: 10602430
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
Nowak R; Oelschlägel U; Range U; Bergmann S; Bornhäuser M; Hölig C; Schuler U; Krebs U; Günther H; Kroschinsky F; Ehninger G
Bone Marrow Transplant; 1999 May; 23(9):895-900. PubMed ID: 10338044
[TBL] [Abstract][Full Text] [Related]
15. X chromosome methylation-based chimerism assay for sex-mismatched hematopoietic stem cell transplantation.
Yamane A; Karasawa M; Maehara T; Tsukamoto N; Nojima Y
Bone Marrow Transplant; 2001 Nov; 28(10):969-73. PubMed ID: 11753553
[TBL] [Abstract][Full Text] [Related]
16. Monitoring and prognostic evaluation of sex-mismatched bone marrow transplantation by competitive PCR on Y chromosome sequences.
Patri S; Dascalesu C; Chomel JC; Sadoun A; Lacotte L; Tanzer J; Guilhot F; Kitzis A
Bone Marrow Transplant; 1996 Apr; 17(4):625-32. PubMed ID: 8722366
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent polymerase chain reaction and capillary electrophoresis for IgH rearrangement and minimal residual disease evaluation in multiple myeloma.
Novella E; Giaretta I; Elice F; Madeo D; Piccin A; Castaman G; Rodeghiero F
Haematologica; 2002 Nov; 87(11):1157-64. PubMed ID: 12414345
[TBL] [Abstract][Full Text] [Related]
18. Minimal residual disease after bone marrow transplantation for multiple myeloma: evidence for cure in long-term survivors.
Bird JM; Russell NH; Samson D
Bone Marrow Transplant; 1993 Dec; 12(6):651-4. PubMed ID: 8136748
[TBL] [Abstract][Full Text] [Related]
19. Long-term persistence of hemopoietic chimerism following sex-mismatched bone marrow transplantation.
Mangioni S; Balduzzi A; Rivolta A; Rovelli A; Nesi F; Rossi V; Busca A; Uderzo C; Miniero R; Biondi A
Bone Marrow Transplant; 1997 Dec; 20(11):969-73. PubMed ID: 9422477
[TBL] [Abstract][Full Text] [Related]
20. Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation.
Fehse B; Chukhlovin A; Kühlcke K; Marinetz O; Vorwig O; Renges H; Krüger W; Zabelina T; Dudina O; Finckenstein FG; Kröger N; Kabisch H; Hochhaus A; Zander AR
J Hematother Stem Cell Res; 2001 Jun; 10(3):419-25. PubMed ID: 11454317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
